U.S. Markets open in 8 hrs 7 mins

Betting on AmerisourceBergen: As Easy as ABC

Paul Price

The pharmaceutical services giant sports a stellar growth record, yet fell out of favor since hitting an all-time peak of $120.70 back in 2015. AmerisourceBergen has a fine balance sheet, is more stable than average and scores in the top 5% of all 1,700 stocks covered in Value Line's main research universe in terms of earnings predictability. Since 2011, AmerisourceBergen averaged about a 15.8x P/E, accompanied by around 1.48% in current yield.